Incomplete tumor volume reduction may improve cancer prognosis

Medical Hypotheses

Volumn 68, Issue 6, 2007, Pages 1236-1239

  Shmilovici, Armin ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SCALPEL; SOLID TUMOR; SURGICAL APPROACH; TECHNIQUE; TUMOR VOLUME; ULTRASOUND; VIRTUAL REALITY;

DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOTHERAPY; MODELS, BIOLOGICAL; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; TUMOR BURDEN;

EID: 33947688238     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.048     Document Type: Article

References (19)

1. Guiot C., Degiorgis P.G., Gabriele P.P., and Deisboeck T.S. Does tumor growth follow a "universal law"?. J Theor Biol 225 (2003) 147-151
2. Deisboeck T.S., Mansury Y., Guiot C., Degiorgis P.G., Giorgio P., and Delsanto P.P. Insights from a novel tumor model: indications for a quantitative link between tumor growth and invasion. Med Hypotheses 65 (2005) 785-790
3. Deisboeck T.S., Guiot C., Delsanto P.P., and Pugno N. Does cancer growth depend on surface extension?. Med Hypotheses 67 (2006) 1338-1341
4. Hosemann S. Redefining unresectable disease strategies for treating liver metastases from colorectal cancer. Oncology 51 4 (2006)
5. Hentschel S.J., and Sawaya R. Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Cont 10 (2003) 109-114
6. Bertelsen K. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol 38 (1990) 203-209
7. Yang S.H., Lee R.C., Chen C.C., Jiang J.K., Lin J.K., Li A.F., et al. Is decrease of tumor volume correlated with stage change after preoperative concurrent chemoradiotherapy?. Hepato-Gastroenterol 52 (2005) 765-769
8. Dolmans D.E.J.G.J., Fukumura D., and Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 3 (2003) 380-387
9. Vrouenraets M.B., Visser G.W.M., Snow G.B., and van Dongen G.A.M.S. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23 (2003) 505-522
10. Blackman G.E., Casciani T., and Bettmann M.A. Direct percutaneous tumor therapy. In: Alison M.R. (Ed). The cancer handbook (2002), Wiley 1261-1267 [chapter 83]
11. Hokland S.L., Pedersen M., Salomir R., Quesson B., Stodkilde-Jorgensen H., and Moonen C.T. MRI-guided focused ultrasound: methodology and applications. IEEE Trans Med Imaging 25 (2006) 723-731
12. Clement G.T. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 42 (2004) 1087-1093
13. Kopelman D., Inbar Y., Hanannel A., Freundlich D., Castel D., Perel A., et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol 59 (2006) 157-162
14. Wu F., Chen W.Z., Bai J., Zou J.Z., Wang Z.L., Zhu H., et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol 28 (2002) 535-542
15. Wu F., Wang Z.B., Chen W.Z., Wang W., Gui Y., Zha M., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 11 (2004) 149-154
16. Furusawa H., Namba K., Thomasen S., Akiyama F., Bendet A., Tanaka C., et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg 203 (2006) 54-63
17. Wu F., Wang Z.B., Jin C.B., Zhang J.P., Chen W.Z., Bai J., et al. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound. Ultrasound Med Biol 30 (2004) 511-517
18. Wu F., Wang Z.B., Lu P., Xu Z.L., Chen W.Z., Zhu H., et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 30 (2004) 1217-1222
19. Rapoport N.Y., Christensen D.A., Fain H.D., Barrows L., and Gao Z. Ultrasound triggered drug targeting of tumors in vitro and in vivo. Ultrasonics 42 (2004) 943-950